secwatch.observer — SEC 8-K summary
======================================

Issuer:     FATE THERAPEUTICS INC (FATE)
CIK:        0001434316
Form:       8-K/A
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001193125-25-142037
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Fate Therapeutics board sets annual say-on-pay votes after stockholder advisory approval
--------------------------------------------------------------------------------

- Stockholders approved advisory vote on executive compensation every one year.
- Board determined to hold non-binding say-on-pay votes annually.
- Next frequency vote required no later than 2031 annual meeting.
- No other changes from original May 30, 2025 8-K reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/0001193125-25-142037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434316/000119312525142037/d35713d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-142037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer